Literature DB >> 33683568

The role of Elabela in kidney disease.

Qian Zheng1, Geng Tian2, Feng Xu1, Xin Ci1, Rumei Luan1, Linlin Wu1, Xuehong Lu3.   

Abstract

Elabela, also known as Toddler or Apela, is a recently discovered hormonal peptide containing 32 amino acids. Elabela is a ligand of the apelin receptor (APJ). APJ is a G protein-coupled receptor widely expressed throughout body, and together with its cognate ligand, apelin, it plays an important role in various physiological processes including cardiovascular functions, angiogenesis and fluid homeostasis. Elabela also participates in embryonic development and pathophysiological processes in adulthood. Elabela is highly expressed in undifferentiated embryonic stem cells and regulates endoderm differentiation and cardiovascular system development. During differentiation, Elabela is highly expressed in pluripotent stem cells and in adult renal collecting ducts and loops, where it functions to maintain water and sodium homeostasis. Other studies have also shown that Elabela plays a crucial role in the pathogenesis of kidney diseases. This review addresses the role of Elabela in kidney diseases including renal ischemia/reperfusion injury, hypertensive nephropathy, diabetic nephropathy, and cardiorenal syndrome.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V. part of Springer Nature.

Entities:  

Keywords:  Apela; Apelin/APJ; Elabela; Kidney diseases; Toddler

Mesh:

Substances:

Year:  2021        PMID: 33683568     DOI: 10.1007/s11255-021-02790-1

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  56 in total

1.  PAK1-cofilin phosphorylation mediates human lung adenocarcinoma cells migration induced by apelin-13.

Authors:  Deguan Lv; Lanfang Li; Qixuan Lu; Yao Li; Feng Xie; Hening Li; Jiangang Cao; Meiqing Liu; Di Wu; Lu He; Linxi Chen
Journal:  Clin Exp Pharmacol Physiol       Date:  2016-05       Impact factor: 2.557

2.  Toddler: an embryonic signal that promotes cell movement via Apelin receptors.

Authors:  Andrea Pauli; Megan L Norris; Eivind Valen; Guo-Liang Chew; James A Gagnon; Steven Zimmerman; Andrew Mitchell; Jiao Ma; Julien Dubrulle; Deepak Reyon; Shengdar Q Tsai; J Keith Joung; Alan Saghatelian; Alexander F Schier
Journal:  Science       Date:  2014-01-09       Impact factor: 47.728

3.  Apela Regulates Fluid Homeostasis by Binding to the APJ Receptor to Activate Gi Signaling.

Authors:  Cheng Deng; Haidi Chen; Na Yang; Yi Feng; Aaron J W Hsueh
Journal:  J Biol Chem       Date:  2015-05-20       Impact factor: 5.157

4.  Small proteins, big roles: the signaling protein Apela extends the complexity of developmental pathways in the early zebrafish embryo.

Authors:  Michal Reichman-Fried; Erez Raz
Journal:  Bioessays       Date:  2014-06-13       Impact factor: 4.345

Review 5.  Apelin and its receptor APJ in cardiovascular diseases.

Authors:  Xiao-Hua Yu; Zhi-Bin Tang; Li-Jing Liu; Hong Qian; Shi-Lin Tang; Da-Wei Zhang; Guo-Ping Tian; Chao-Ke Tang
Journal:  Clin Chim Acta       Date:  2013-09-18       Impact factor: 3.786

6.  ELABELA: a hormone essential for heart development signals via the apelin receptor.

Authors:  Serene C Chng; Lena Ho; Jing Tian; Bruno Reversade
Journal:  Dev Cell       Date:  2013-12-05       Impact factor: 12.270

Review 7.  Apelin/APJ system: A novel promising therapy target for pathological angiogenesis.

Authors:  Lele Wu; Linxi Chen; Lanfang Li
Journal:  Clin Chim Acta       Date:  2016-12-23       Impact factor: 3.786

8.  ELABELA Is an Endogenous Growth Factor that Sustains hESC Self-Renewal via the PI3K/AKT Pathway.

Authors:  Lena Ho; Shawn Y X Tan; Sheena Wee; Yixuan Wu; Sam J C Tan; Navin B Ramakrishna; Serene C Chng; Srikanth Nama; Iwona Szczerbinska; Iwona Sczerbinska; Yun-Shen Chan; Stuart Avery; Norihiro Tsuneyoshi; Huck Hui Ng; Jayantha Gunaratne; N Ray Dunn; Bruno Reversade
Journal:  Cell Stem Cell       Date:  2015-09-17       Impact factor: 24.633

9.  Endothelial APLNR regulates tissue fatty acid uptake and is essential for apelin's glucose-lowering effects.

Authors:  Cheol Hwangbo; Jingxia Wu; Irinna Papangeli; Takaomi Adachi; Bikram Sharma; Saejeong Park; Lina Zhao; Hyekyung Ju; Gwang-Woong Go; Guoliang Cui; Mohammed Inayathullah; Judith K Job; Jayakumar Rajadas; Stephanie L Kwei; Ming O Li; Alan R Morrison; Thomas Quertermous; Arya Mani; Kristy Red-Horse; Hyung J Chun
Journal:  Sci Transl Med       Date:  2017-09-13       Impact factor: 17.956

10.  Elabela-apelin receptor signaling pathway is functional in mammalian systems.

Authors:  Zhi Wang; Daozhan Yu; Mengqiao Wang; Qilong Wang; Jennifer Kouznetsova; Rongze Yang; Kun Qian; Wenjun Wu; Alan Shuldiner; Carole Sztalryd; Minghui Zou; Wei Zheng; Da-Wei Gong
Journal:  Sci Rep       Date:  2015-02-02       Impact factor: 4.379

View more
  3 in total

1.  Evaluation of Apelin-13 levels in patients with diabetic nephropathy.

Authors:  Gamze İçen; Gülçin Dağlıoğlu; Mehtap Evran
Journal:  Int Urol Nephrol       Date:  2022-08-04       Impact factor: 2.266

Review 2.  Potential Therapeutic Role for Apelin and Related Peptides in Diabetes: An Update.

Authors:  Ethan S Palmer; Nigel Irwin; Finbarr Pm O'Harte
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2022-02-11

Review 3.  The Role of Apelin-APJ System in Diabetes and Obesity.

Authors:  Cheng Li; Hongna Cheng; Binay Kumar Adhikari; Shudong Wang; Na Yang; Wenyun Liu; Jian Sun; Yonggang Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-09       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.